---
$id: https://graph.org.ai/products/commodity/51141577
$type: Product
source: UNSPSC
code: "51141577"
title: "Ropizine"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ropizine

**UNSPSC Code**: 51141577
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q5128GW9D4. European Medicines Agency schedules Ropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10383MIG. Ropizine generally arises in the molecular formula C24H26N4. The term ROPIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) ROPIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ropizine under HS 29335995 and SITC 51576. As of Q4 2014, ROPIZINE remains the US FDA Preferred Term for this commodity. Ropizine bears US NLM identifiers UMLS ID C0073572 and NCI Concept Code C75166. SMILES: N1(C(C2CCCCC2)C2CCCCC2)CCN(/N=C/C2NC(CCC2)C)CC1.

